Trial Profile
Velphoro and impact on the oral cavity and gut microbiome
Status:
Discontinued
Phase of Trial:
Phase IV
Latest Information Update: 03 Oct 2021
Price :
$35
*
At a glance
- Drugs Sucroferric oxyhydroxide (Primary)
- Indications Hyperphosphataemia
- Focus Pharmacodynamics
- Acronyms Microbiom-Eisen
- 06 Nov 2020 Status changed from recruiting to discontinued.
- 27 Jul 2020 Status changed from suspended to recruiting.
- 08 May 2020 Status changed from recruiting to suspended.